0.661
price up icon1.41%   0.0092
after-market Dopo l'orario di chiusura: .70 0.039 +5.90%
loading

Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
9.27%
17.10
18.84 19.10 20.79 21.61
Nonoperating Income/Loss
7.49%
2.064
2.231 2.654 2.779 2.877
Income/Loss From Continuing Operations Before Tax
9.51%
-15.03
-16.61 -16.45 -18.01 -18.73
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
9.51%
-15.03
-16.61 -16.45 -18.01 -18.73
Net Income/Loss
9.51%
-15.03
-16.61 -16.45 -18.01 -18.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.05%
126.20
126.14 125.45 125.32 125.14
Diluted Average Shares
0.05%
126.20
126.14 125.45 125.32 125.14
Basic Earnings Per Share
7.69%
-0.12
-0.13 -0.13 -0.14 -0.15
Diluted Earnings Per Share
7.69%
-0.12
-0.13 -0.13 -0.14 -0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):